Lunai Bioworks Inc. (LNAI) Stock Ticker
Market factors today
Unlock the full LNAI picture
About Lunai Bioworks Inc.
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
LNAI stock facts
| Ticker symbol | LNAI |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $8.8M |
| CEO | David H. Weinstein |
| Employees | 29 |
| Headquarters | Los Angeles, CA, US |
| IPO date | 2025-09-30 |
| Website | www.lunaibioworks.com |
What you can see for LNAI on Tickr
Live LNAI price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LNAI report.
Rankings
FAQ
What is the ticker symbol for Lunai Bioworks Inc.?
The ticker symbol for Lunai Bioworks Inc. is LNAI, listed on the NASDAQ Global Market.
What is LNAI?
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."